ADELAIDE, Australia, May 22, 2019 /PRNewswire/ — Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that the US Food and Drug Administration (FDA) has approved Sorilux (calcipotriene) Foam, 0.005% in adolescents. Sorilux is now approved…Original Article
FDA Approves Sorilux for Adolescent Plaque Psoriasis
